| Shruti A Shah, MD | |
|
225 State Route 35 Ste 102b, Red Bank, NJ 07701-5933 | |
| (732) 665-6492 | |
| Not Available |
| Full Name | Shruti A Shah |
|---|---|
| Gender | Female |
| Speciality | Pain Management |
| Experience | 29 Years |
| Location | 225 State Route 35 Ste 102b, Red Bank, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114158755 | NPI | - | NPPES |
| P00953302 | Other | NJ | RR MCR PTAN |
| P00953311 | Other | NJ | RR MCR PTAN |
| 0209015 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA08317800 (New Jersey) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 25MA08317800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Medical Center | Red bank, NJ | Hospital |
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Ocean Medical Center | Brick, NJ | Hospital |
| Entity Name | Rutgers Health-rwj Anesthesiology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861414989 PECOS PAC ID: 2264346493 Enrollment ID: O20031113000072 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Entity Name | Rutgers Health-rwj Acute Pain |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063420776 PECOS PAC ID: 0244144491 Enrollment ID: O20031113000177 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Entity Name | Seaview Orthopaedics & Medical Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982618757 PECOS PAC ID: 7810983210 Enrollment ID: O20040421001657 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Entity Name | Rutgers Health-rwj Pain Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982798922 PECOS PAC ID: 6002802600 Enrollment ID: O20050923000044 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Entity Name | Red Bank Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871764530 PECOS PAC ID: 2567520380 Enrollment ID: O20081023000423 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Entity Name | Liberty Pain Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801306956 PECOS PAC ID: 9537433750 Enrollment ID: O20170926003106 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shruti A Shah, MD 225 State Route 35 Ste 102b, Red Bank, NJ 07701-5933 Ph: (732) 665-6492 | Shruti A Shah, MD 225 State Route 35 Ste 102b, Red Bank, NJ 07701-5933 Ph: (732) 665-6492 |
News Archive
Predicting influenza outbreaks just got a little easier, thanks to a new A.I.-powered forecasting tool developed by researchers at Stevens Institute of Technology.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today new positive results from its Phase 1/2 study with lumasiran, an investigational RNAi therapeutic targeting glycolate oxidase for the treatment of Primary Hyperoxaluria Type 1.
Black women living in South Carolina are more likely to develop and die from breast and cervical cancers, compared to white women, according to a study published in the Journal of the South Carolina Medical Association, the AP/WHNS reports.
Neuroinformatics scientists at Osnabrück University and data specialists at Forschungszentrum Jülich are releasing new model results daily to forecast COVID-19 infections.
› Verified 9 days ago
James R Dooley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plz, Red Bank, NJ 07701 Phone: 732-741-2700 | |
Vijayalaxmi Varadarajan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plz, Red Bank, NJ 07701 Phone: 732-741-2700 | |
Andrew A Assiamah, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plaza, Red Bank, NJ 07701 Phone: 856-829-9345 | |
Daran Haber, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plz, Red Bank, NJ 07701 Phone: 732-741-2700 | |
Khanh Q Nguyen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plz, Red Bank, NJ 07701 Phone: 732-741-2700 | |
Joseph J Sestito Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Riverview Plz, Red Bank, NJ 07701 Phone: 732-741-2700 |